Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy
- PMID: 30363715
- PMCID: PMC6181007
- DOI: 10.1155/2018/6238978
Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy
Abstract
With the advent of antiretroviral therapy (ART), HIV-infected individuals are now living longer and healthier lives. However, ART does not completely restore health and treated individuals are experiencing increased rates of noncommunicable diseases such as dyslipidemia, insulin resistance, type 2 diabetes, cardiovascular disease, and nonalcoholic fatty liver disease. While it is well known that persistent immune activation and inflammation contribute to the development of these comorbid diseases, the mechanisms underlying this chronic activation remain incompletely understood. In this review, we will discuss emerging evidence that suggests that alterations in cellular metabolism may play a central role in driving this immune dysfunction in HIV patients on ART.
References
-
- Antiretroviral Therapy Cohort Collaboration, Zwahlen M., Harris R., et al. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. International Journal of Epidemiology. 2009;38(6):1624–1633. doi: 10.1093/ije/dyp306. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
